Trident Texofab standalone net profit rises 666.67% in the December 2022 quarter
Sales rise 2.94% to Rs 24.55 crore
Net profit of Trident Texofab rose 666.67% to Rs 1.15 crore in the quarter ended December 2022 as against Rs 0.15 crore during the previous quarter ended December 2021. Sales rose 2.94% to Rs 24.55 crore in the quarter ended December 2022 as against Rs 23.85 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales24.5523.85 3 OPM %8.846.75 -PBDT1.990.97 105 PBT1.590.58 174 NP1.150.15 667Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 16 2023 | 3:39 PM IST